About Lila Biologics
Lila Biologics is a private company based in Seattle, Washington, incorporated in 2022 in Delaware. It has reported $9,537,323 raised in one offering on Form D since September 2023. Its chief executive is John Kraft, II.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 14, 2023 | Sep 28, 2023 | $9,537,323of $10.5M target | 18 | $529K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Lila Biologics's Form D filed Sep 28, 2023.
WC
William Canestaro
Director
SG
Sheila Gujrathi
Director
JI
John Kraft, II
Chief Executive Officer and director
AR
Anindya Roy
Executive officer and director